<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-20T00:12:01Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2072/458118" metadataPrefix="rdf">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2072/458118</identifier><datestamp>2025-05-28T03:37:53Z</datestamp><setSpec>com_2072_98</setSpec><setSpec>col_2072_378192</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:recercat.cat:2072/458118">
      <dc:title>Human-induced neural and mesenchymal stem cell therapy combined with a curcumin nanoconjugate as a spinal cord injury treatment</dc:title>
      <dc:creator>Bonilla, Pablo</dc:creator>
      <dc:creator>Hernández Martín, Joaquim</dc:creator>
      <dc:creator>Giraldo, Esther</dc:creator>
      <dc:creator>González-Pérez, Miguel A.</dc:creator>
      <dc:creator>Alastrue-Agudo, Ana</dc:creator>
      <dc:creator>Elkhenany, Hoda</dc:creator>
      <dc:creator>Vicent, María J.</dc:creator>
      <dc:creator>Navarro, X. (Xavier)</dc:creator>
      <dc:creator>Edel, Michael J.</dc:creator>
      <dc:creator>Moreno-Manzano, Victoria</dc:creator>
      <dc:subject>Spinal cord injury</dc:subject>
      <dc:subject>Stem cells</dc:subject>
      <dc:subject>Curcumin</dc:subject>
      <dc:subject>Neuroprotection</dc:subject>
      <dc:subject>Polymer-drug conjugate</dc:subject>
      <dc:description>Altres ajuts: Fundació Marató TV3 2017/refs.20172230, 20172231 i 20172110</dc:description>
      <dc:description>We currently lack effective treatments for the devastating loss of neural function associated with spinal cord injury (SCI). In this study, we evaluated a combination therapy comprising human neural stem cells derived from induced pluripotent stem cells (iPSC-NSC), human mesen-chymal stem cells (MSC), and a pH-responsive polyacetal-curcumin nanoconjugate (PA-C) that al-lows the sustained release of curcumin. In vitro analysis demonstrated that PA-C treatment pro-tected iPSC-NSC from oxidative damage in vitro, while MSC co-culture prevented lipopolysaccha-ride-induced activation of nuclear factor-κB (NF-κB) in iPSC-NSC. Then, we evaluated the combination of PA-C delivery into the intrathecal space in a rat model of contusive SCI with stem cell transplantation. While we failed to observe significant improvements in locomotor function (BBB scale) in treated animals, histological analysis revealed that PA-C-treated or PA-C and iPSC-NSC + MSC-treated animals displayed significantly smaller scars, while PA-C and iPSC-NSC + MSC treatment induced the preservation of β-III Tubulin-positive axons. iPSC-NSC + MSC transplantation fostered the preservation of motoneurons and myelinated tracts, while PA-C treatment polarized microglia into an anti-inflammatory phenotype. Overall, the combination of stem cell transplantation and PA-C treatment confers higher neuroprotective effects compared to individual treatments.</dc:description>
      <dc:date>2021</dc:date>
      <dc:type>Article</dc:type>
      <dc:relation>Agencia Estatal de Investigación RTI2018-095872-B-C21</dc:relation>
      <dc:relation>International journal of molecular sciences ; Vol. 22, Issue 11 (June 2021), art. 5966</dc:relation>
      <dc:rights>open access</dc:rights>
      <dc:rights>Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.</dc:rights>
      <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:publisher/>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>